Recent publications highlight the low reproducibility rate of preclinical research and the issues that surround it. Various sources for this irreproducibility can be grouped into four main categories: study design, laboratory protocols, data analysis and reporting, and the actual biological reagents and reference materials used. Improvement efforts for biological reagents have primarily focused on validating antibodies and authenticating cell lines, two areas where significant improvement opportunities exist.
What about other agents like buffers? These ubiquitous life science products are often overlooked as a source of variability in experiments, yet they can have a significant contribution to reproducibility. Since buffers are so widely used across most life science applications and workflows, there is a need for better understanding and training on their selection and use.
Watch this informative webinar in which our experts will explore ways to improve reproducibility when using biological buffers.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.